Results 221 to 230 of about 50,141 (259)

Cardiovascular Outcomes and Hyperkalemia Risk in Patients With Diabetes, Chronic Kidney Disease and Heart Failure: A Real-World Comparison of Non-steroidal versus Steroidal Mineralocorticoid Receptor Antagonists. [PDF]

Cureus
Okunlola AO, Kolawole O, Otabor E, Hassan A, Hamilton M, Alomari L, Lam J, Idowu AB.   +7 more
europepmc   +1 more source

2025 Update on resistant hypertension in CKD: where do we stand and where do we go? [PDF]

Clin Kidney J
Schmieder RE.
europepmc   +1 more source

Evaluation of 17β-Estradiol Administration by Subcutaneous Injections in Transgender Women. [PDF]

J Endocr Soc
Moreau HM, Perkins H, LaBudde J, Craig WY, Spratt DI.   +4 more
europepmc   +1 more source

Concerns Regarding Renal Function Claims in Low-Dose Spironolactone Study. [PDF]

Endocrinol Diabetes Metab
Helvacı Ö, Helvacı BC.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Novel spironolactone-analogs as impurities in spironolactone

Steroids, 2004
Six novel spironolactone-analogs steroids (3-8) were isolated from spironolactone by using various chromatographic methods. Their structures were elucidated by spectrometric analysis. Two of the analogs (3 and 7) were confirmed by X-ray crystallography.
Hua, Chen, Xiao-Yi, Wang, Zhong-Duo, Yang, Yuan-Chao, Li   +3 more
openaire   +2 more sources

Spironolactone

Neonatal Network, 1999
DIURETICS ARE COMMONLY USED IN the neonatal intensive care unit (NICU) to remove excess extracellular fluid secondary to various diseases, such as chronic lung disease (CLD) and congestive heart failure (CHF). Diuretics are among the most used of all medications across age groups.
openaire   +2 more sources